Evidence map›Paper›PMID 32885688›Full record

ArticleDrug delivery2020

A promising drug delivery candidate (CS-g-PMDA-CYS-fused gold nanoparticles) for inhibition of multidrug-resistant uropathogenic

Ping Shi, Rajendran Amarnath Praphakar, Sadhasivan Deepa, Kannan Suganya, Prashant Gupta, Riaz Ullah, Ahmed Bari, Marudhamuthu Murugan, Mariappan Rajan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug delivery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Ping ShiManagement Office of Drug Clinical Trial Research, Affiliated Hospital of Qingdao University, Qingdao, Shandong.
Rajendran Amarnath PraphakarBiomaterials in Medicinal Chemistry Laboratory, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, India.
Sadhasivan DeepaBiomaterials in Medicinal Chemistry Laboratory, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, India.
Kannan SuganyaDepartment of Microbial Technology, School of Biological Sciences, Madurai Kamaraj University, Madurai, India.
Prashant GuptaDepartment of Balroga, Govt. Ayurved College, Raipur, Chhattisgarh, India.
Riaz UllahDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Ahmed BariDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Marudhamuthu MuruganDepartment of Microbial Technology, School of Biological Sciences, Madurai Kamaraj University, Madurai, India.
Mariappan RajanBiomaterials in Medicinal Chemistry Laboratory, Department of Natural Products Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai, India.ORCID https://orcid.org/0000-0001-9569-8744
Madurai Kamaraj University · INKing Saud University · SAQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance amongst microbial pathogens is a mounting serious issue in researchers and physicians. Various alternatives to overcome the multidrug-resistant bacterial infections are under search, and biofilm growth inhibition is one of them. In this investigation, a polymeric drug delivery system loaded with multi-serratial drugs to improve the delivery of drugs against urinary tract infection causative

Indexed as

AnimalsAnti-Bacterial AgentsBenzoatesCaenorhabditis elegansChitosanCysteineDrug Delivery SystemsDrug Resistance, Multiple, BacterialGold CompoundsMetal NanoparticlesMicrobial Sensitivity TestsSerratia InfectionsSerratia marcescensUrinary Tract InfectionsX-Ray DiffractionAnti-Bacterial AgentsBenzoatesChitosanCysteinegold chlorideGold Compoundspyromellitic dianhydrideAntibiotic resistancegold nanoparticlepH-sensitive drug deliverySerratia marcescens

Identifiers

PMID32885688
PMCPMC8216475
OpenAlexW3083443411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.